Physician profile
Richard Longley
NPI 1629055967
$3,076.80
in general payments reported to CMS, 2019-2025
27 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $975 · 2020: $872 · 2021: $662 · 2022: $431 · 2023: $136.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $121.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $121.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $414.58 | 2019-2023 | Grafix Pl, Regranex, Collagenase Santyl |
| Sanofi-Aventis U.S. LLC | $380.48 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $332.85 | 2019-2021 | |
| Abbott Laboratories | $268.09 | 2019-2020 | |
| Lilly USA, LLC | $226.43 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $150.37 | 2021-2022 | |
| Organogenesis INC. | $131.35 | 2019-2022 | |
| Esperion Therapeutics, INC. | $126.65 | 2020-2021 | |
| Novo Nordisk INC | $110.02 | 2019-2021 | |
| Corcept Therapeutics | $108.63 | 2019-2021 | |
| Kerecis Limited | $100.00 | 2022 | |
| Ekos Corporation | $93.33 | 2019 | |
| Merck Sharp & Dohme LLC | $91.36 | 2020 | |
| Dexcom, INC. | $89.34 | 2021-2022 | |
| Abbvie INC. | $86.01 | 2019-2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xeris Pharmaceuticals, INC. | $74.49 | 2021-2023 | Gvoke Hypopen |
| Insulet Corporation | $49.21 | 2019-2021 | |
| Cardiovascular Systems INC. | $48.20 | 2019 | |
| Convatec INC. | $31.26 | 2019-2022 | |
| Integra Lifesciences Corporation | $29.57 | 2022 | |
| Shire North American Group INC | $24.45 | 2019 | |
| Amneal Pharmaceuticals LLC | $18.99 | 2019 | |
| Janssen Pharmaceuticals, INC | $17.22 | 2019 | |
| Horizon Therapeutics Plc | $16.08 | 2022 | |
| Medtronic Minimed, INC. | $15.60 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.55 | 2021 | |
| Acera Surgical, INC. | $12.44 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Longley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.